Decheng Capital LLC

Investment Portfolio & 13F Holdings Analysis

About

CIK: 0002010850

Type: FundHoldings: 27Value: $356.5MLatest: 2025Q1

Decheng Capital LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 27 holdings worth $0.4 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "KRYS",
  "NAMS",
  "RVMD",
  "EQ",
  "RCUS",
  null,
  "NUVB",
  "LEGN",
  "BYSI",
  "LYEL",
  "PYXS",
  null,
  "ACRS",
  "ILMN",
  "AURA",
  "UPB",
  "FDMT",
  "ACLX",
  "GRAL",
  null,
  "ZNTL",
  "VERA",
  "BNTX",
  "CGON",
  "CRNX",
  "CYTK"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-08
Total Holdings: 27
Total Value: 356489453
Accession Number: 0001104659-25-045686
Form Type: 13F-HR
CIK: decheng-capital
Manager Name: Decheng-Capital

Data Enrichment

89% identified

24 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

27 positions • $356.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

CG Oncology, Inc.

CGON|156944100

Shares:6.4M

Value:$156.0M

% of Portfolio:43.8% ($156.0M/$356.5M)

Nuvation Bio Inc.

NUVB|67080N101

Shares:26.0M

Value:$45.7M

% of Portfolio:12.8% ($45.7M/$356.5M)

002942100

Shares:3.9M

Value:$29.4M

% of Portfolio:8.3% ($29.4M/$356.5M)

Upstream Bio, Inc.

UPB|91678A107

Shares:3.3M

Value:$20.1M

% of Portfolio:5.6% ($20.1M/$356.5M)

NewAmsterdam Pharma Co N.V.

NAMS|N62509109

Shares:770.0K

Value:$15.8M

% of Portfolio:4.4% ($15.8M/$356.5M)

Krystal Biotech, Inc.

KRYS|501147102

Shares:65.0K

Value:$11.7M

% of Portfolio:3.3% ($11.7M/$356.5M)

Revolution Medicines, Inc.

RVMD|76155X100

Shares:226.0K

Value:$8.0M

% of Portfolio:2.2% ($8.0M/$356.5M)

Merus N.V.

MRUS|N5749R100

Shares:189.1K

Value:$8.0M

% of Portfolio:2.2% ($8.0M/$356.5M)

BeyondSpring Inc.

BYSI|G10830100

Shares:4.9M

Value:$7.0M

% of Portfolio:2.0% ($7.0M/$356.5M)

G4444C102

Shares:171.6K

Value:$6.7M

% of Portfolio:1.9% ($6.7M/$356.5M)

Lyell Immunopharma, Inc.

LYEL|55083R104

Shares:11.9M

Value:$6.4M

% of Portfolio:1.8% ($6.4M/$356.5M)

Arcus Biosciences, Inc.

RCUS|03969F109

Shares:808.8K

Value:$6.3M

% of Portfolio:1.8% ($6.3M/$356.5M)

Aclaris Therapeutics, Inc.

ACRS|00461U105

Shares:4.0M

Value:$6.2M

% of Portfolio:1.7% ($6.2M/$356.5M)

Crinetics Pharmaceuticals, Inc.

CRNX|22663K107

Shares:178.0K

Value:$6.0M

% of Portfolio:1.7% ($6.0M/$356.5M)

CYTOKINETICS INC

CYTK|23282W605

Shares:100.0K

Value:$4.0M

% of Portfolio:1.1% ($4.0M/$356.5M)

Legend Biotech Corp

LEGN|52490G102

Shares:100.0K

Value:$3.4M

% of Portfolio:1.0% ($3.4M/$356.5M)

Arcellx, Inc.

ACLX|03940C100

Shares:50.0K

Value:$3.3M

% of Portfolio:0.9% ($3.3M/$356.5M)

Zentalis Pharmaceuticals, Inc.

ZNTL|98943L107

Shares:2.0M

Value:$3.2M

% of Portfolio:0.9% ($3.2M/$356.5M)

Aura Biosciences, Inc.

AURA|05153U107

Shares:515.6K

Value:$3.0M

% of Portfolio:0.8% ($3.0M/$356.5M)

BioNTech SE

BNTX|09075V102

Shares:20.0K

Value:$1.8M

% of Portfolio:0.5% ($1.8M/$356.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
CG Oncology, Inc.(CGONcusip156944100)	6.4M	QoQ 0.00% (-0) YoY +16.72% (-912.9K)	All Managers (Combined)	$156.0M	43.8% ($156.0M/$356.5M)	QoQ -14.60% (-$26.7M) YoY -34.88% (-$83.6M)
Nuvation Bio Inc.(NUVBcusip67080N101)	26.0M	QoQ 0.00% (-0) YoY NEW(+26.0M)	All Managers (Combined)	$45.7M	12.8% ($45.7M/$356.5M)	QoQ -33.83% (-$23.4M) YoY NEW(+$45.7M)
(cusip002942100)✕	3.9M	QoQ NEW(+3.9M) YoY NEW(+3.9M)	All Managers (Combined)	$29.4M	8.3% ($29.4M/$356.5M)	QoQ NEW(+$29.4M) YoY NEW(+$29.4M)
Upstream Bio, Inc.(UPBcusip91678A107)	3.3M	QoQ 0.00% (-0) YoY NEW(+3.3M)	All Managers (Combined)	$20.1M	5.6% ($20.1M/$356.5M)	QoQ -62.77% (-$33.9M) YoY NEW(+$20.1M)
NewAmsterdam Pharma Co N.V.(NAMScusipN62509109)	770.0K	QoQ 0.00% (-0) YoY NEW(+770.0K)	All Managers (Combined)	$15.8M	4.4% ($15.8M/$356.5M)	QoQ -20.35% (-$4.0M) YoY NEW(+$15.8M)
Krystal Biotech, Inc.(KRYScusip501147102)	65.0K	QoQ -15.33% (-11.8K) YoY -1.17% (-772)	All Managers (Combined)	$11.7M	3.3% ($11.7M/$356.5M)	QoQ -2.55% (-$307.6K) YoY +0.14% (-$16.7K)
Revolution Medicines, Inc.(RVMDcusip76155X100)	226.0K	QoQ 0.00% (-0) YoY NEW(+226.0K)	All Managers (Combined)	$8.0M	2.2% ($8.0M/$356.5M)	QoQ -19.15% (-$1.9M) YoY NEW(+$8.0M)
Merus N.V.(MRUScusipN5749R100)	189.1K	QoQ 0.00% (+0) YoY +85.75% (+87.3K)	All Managers (Combined)	$8.0M	2.2% ($8.0M/$356.5M)	QoQ +0.09% (+$7.6K) YoY +73.62% (+$3.4M)
BeyondSpring Inc.(BYSIcusipG10830100)	4.9M	QoQ 0.00% (-0) YoY -1.52% (-75.5K)	All Managers (Combined)	$7.0M	2.0% ($7.0M/$356.5M)	QoQ -12.40% (-$987.1K) YoY -60.61% (-$10.7M)
(cusipG4444C102)✕	171.6K	QoQ 0.00% (-0) YoY +3.00% (-5.0K)	All Managers (Combined)	$6.7M	1.9% ($6.7M/$356.5M)	QoQ -27.84% (-$2.6M) YoY -19.88% (-$1.7M)
Lyell Immunopharma, Inc.(LYELcusip55083R104)	11.9M	QoQ 0.00% (-0) YoY NEW(+11.9M)	All Managers (Combined)	$6.4M	1.8% ($6.4M/$356.5M)	QoQ -15.93% (-$1.2M) YoY NEW(+$6.4M)
Arcus Biosciences, Inc.(RCUScusip03969F109)	808.8K	QoQ 0.00% (-0) YoY -7.01% (-61.0K)	All Managers (Combined)	$6.3M	1.8% ($6.3M/$356.5M)	QoQ -47.28% (-$5.7M) YoY -61.33% (-$10.1M)
Aclaris Therapeutics, Inc.(ACRScusip00461U105)	4.0M	QoQ +78.31% (+1.8M) YoY NEW(+4.0M)	All Managers (Combined)	$6.2M	1.7% ($6.2M/$356.5M)	QoQ +10.00% (+$562.5K) YoY NEW(+$6.2M)
Crinetics Pharmaceuticals, Inc.(CRNXcusip22663K107)	178.0K	QoQ +5.95% (-10.0K) YoY +12.66% (-20.0K)	All Managers (Combined)	$6.0M	1.7% ($6.0M/$356.5M)	QoQ -30.49% (-$2.6M) YoY -19.27% (-$1.4M)
CYTOKINETICS INC(CYTKcusip23282W605)	100.0K	QoQ 0.00% (-0) YoY +6.33% (-6.0K)	All Managers (Combined)	$4.0M	1.1% ($4.0M/$356.5M)	QoQ -14.56% (-$685.0K) YoY -39.04% (-$2.6M)
Legend Biotech Corp(LEGNcusip52490G102)	100.0K	QoQ -34.87% (-53.6K) YoY +15.79% (-13.6K)	All Managers (Combined)	$3.4M	1.0% ($3.4M/$356.5M)	QoQ -32.09% (-$1.6M) YoY -29.95% (-$1.5M)
Arcellx, Inc.(ACLXcusip03940C100)	50.0K	QoQ -40.74% (-34.4K) YoY NEW(+50.0K)	All Managers (Combined)	$3.3M	0.9% ($3.3M/$356.5M)	QoQ -49.31% (-$3.2M) YoY NEW(+$3.3M)
Zentalis Pharmaceuticals, Inc.(ZNTLcusip98943L107)	2.0M	QoQ -13.61% (-318.3K) YoY -3.80% (-79.8K)	All Managers (Combined)	$3.2M	0.9% ($3.2M/$356.5M)	QoQ -54.66% (-$3.9M) YoY -90.29% (-$29.9M)
Aura Biosciences, Inc.(AURAcusip05153U107)	515.6K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.0M	0.8% ($3.0M/$356.5M)	QoQ -28.71% (-$1.2M) YoY -25.35% (-$1.0M)
BioNTech SE(BNTXcusip09075V102)	20.0K	QoQ -50.00% (-20.0K) YoY NEW(+20.0K)	All Managers (Combined)	$1.8M	0.5% ($1.8M/$356.5M)	QoQ -60.04% (-$2.7M) YoY NEW(+$1.8M)